DE60014575D1 - Stabilisierende Peptide, und Polypeptide und Antikörper die diese beinhalten - Google Patents

Stabilisierende Peptide, und Polypeptide und Antikörper die diese beinhalten

Info

Publication number
DE60014575D1
DE60014575D1 DE60014575T DE60014575T DE60014575D1 DE 60014575 D1 DE60014575 D1 DE 60014575D1 DE 60014575 T DE60014575 T DE 60014575T DE 60014575 T DE60014575 T DE 60014575T DE 60014575 D1 DE60014575 D1 DE 60014575D1
Authority
DE
Germany
Prior art keywords
polypeptides
peptides
antibodies containing
antibodies
stabilizing peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60014575T
Other languages
English (en)
Other versions
DE60014575T2 (de
Inventor
Eugenio Benvenuto
Rosella Franconi
Angiola Desiderio
Paraskevi Tavladoraki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agenzia Nazionale per le Nuove Tecnologie lEnergia e lo Sviluppo Economico Sostenibile ENEA
Original Assignee
Agenzia Nazionale per le Nuove Tecnologie lEnergia e lo Sviluppo Economico Sostenibile ENEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agenzia Nazionale per le Nuove Tecnologie lEnergia e lo Sviluppo Economico Sostenibile ENEA filed Critical Agenzia Nazionale per le Nuove Tecnologie lEnergia e lo Sviluppo Economico Sostenibile ENEA
Publication of DE60014575D1 publication Critical patent/DE60014575D1/de
Application granted granted Critical
Publication of DE60014575T2 publication Critical patent/DE60014575T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/13—Immunoglobulins specific features characterized by their source of isolation or production isolated from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60014575T 1999-12-30 2000-12-21 Stabilisierende Peptide, und Polypeptide und Antikörper die diese beinhalten Expired - Lifetime DE60014575T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000803A IT1307309B1 (it) 1999-12-30 1999-12-30 Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
ITRM990803 1999-12-30

Publications (2)

Publication Number Publication Date
DE60014575D1 true DE60014575D1 (de) 2004-11-11
DE60014575T2 DE60014575T2 (de) 2005-10-13

Family

ID=11407125

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014575T Expired - Lifetime DE60014575T2 (de) 1999-12-30 2000-12-21 Stabilisierende Peptide, und Polypeptide und Antikörper die diese beinhalten

Country Status (10)

Country Link
US (1) US20030157090A1 (de)
EP (1) EP1120464B1 (de)
JP (1) JP2003518941A (de)
AT (1) ATE278778T1 (de)
AU (1) AU2397701A (de)
CA (1) CA2395041A1 (de)
DE (1) DE60014575T2 (de)
IL (1) IL150067A0 (de)
IT (1) IT1307309B1 (de)
WO (1) WO2001049713A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7481999B2 (en) 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
WO2003025124A2 (en) * 2001-09-14 2003-03-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Immunoglobulin having particular framework scaffold and methods of making and using
AU2002351896A1 (en) * 2001-12-11 2003-06-23 Ablynx N.V. Method for displaying loops from immunoglobulin domains in different contexts
WO2003054021A2 (en) * 2001-12-20 2003-07-03 Agricultural Research Council Semi-synthetic antibody fragment combinatorial library based on avian immunoglobulin genes
US7047448B2 (en) * 2002-11-21 2006-05-16 Bitfone Corporation Software self-repair toolkit for electronic devices
US8663650B2 (en) 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
EP1500662A3 (de) * 2003-05-19 2005-09-21 Cornell Research Foundation, Inc. Stabilisierende Peptide und Ihre Verwendung zur Herstellung von stabilisierten HIV-Inhibitoren
DOP2006000277A (es) 2005-12-12 2007-08-31 Bayer Pharmaceuticals Corp Anticuerpos anti mn y métodos para su utilización
WO2009010733A2 (en) * 2007-07-15 2009-01-22 Zealand Pharma A/S Peptide gap junction modulators
CA2749093C (en) * 2009-01-08 2019-03-26 Bio-Rad Laboratories, Inc. Exonuclease deficient hybrid polymerase and uses thereof in amplification reactions
WO2011063237A2 (en) 2009-11-19 2011-05-26 Oncomed Pharmaceuticals, Inc. Jagged-binding agents and uses thereof
UA123257C2 (uk) * 2010-02-24 2021-03-10 Іммуноджен, Інк. Виділений поліпептид, що кодує антитіло до рецептора фолієвої кислоти 1
PT2694106T (pt) 2011-04-01 2018-03-05 Immunogen Inc Métodos para aumentar eficácia de terapia de cancro de folr1
WO2013023251A1 (en) 2011-08-18 2013-02-21 Affinity Biosciences Pty Ltd Soluble polypeptides
NZ726258A (en) 2012-08-31 2019-07-26 Immunogen Inc Antibodies and uses thereof to detect folate receptor 1
SG10201907501QA (en) 2013-08-30 2019-10-30 Immunogen Inc Antibodies and assays for detection of folate receptor 1
KR102700777B1 (ko) 2015-09-17 2024-08-29 이뮤노젠 아이엔씨 항-folr1 면역접합체를 포함하는 치료제 조합
CA3128368A1 (en) * 2019-02-01 2020-08-06 Memorial Sloan Kettering Cancer Center Senolytic car-t cells targeting upar, a cell surface and secreted senescence biomarker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins

Also Published As

Publication number Publication date
ITRM990803A1 (it) 2001-06-30
JP2003518941A (ja) 2003-06-17
WO2001049713A3 (en) 2002-01-03
EP1120464A2 (de) 2001-08-01
CA2395041A1 (en) 2001-07-12
EP1120464A3 (de) 2001-10-24
US20030157090A1 (en) 2003-08-21
WO2001049713A2 (en) 2001-07-12
DE60014575T2 (de) 2005-10-13
EP1120464B1 (de) 2004-10-06
ATE278778T1 (de) 2004-10-15
IL150067A0 (en) 2002-12-01
AU2397701A (en) 2001-07-16
IT1307309B1 (it) 2001-10-30
ITRM990803A0 (it) 1999-12-30

Similar Documents

Publication Publication Date Title
DE60014575D1 (de) Stabilisierende Peptide, und Polypeptide und Antikörper die diese beinhalten
ID28070A (id) Kalsium (3s) tetrahidro-3-furanil (1s,2r)-3-((4-aminofenil) sulfonil) (isobutil) amino)-1-benzil-2-(fosfonooksi) propilkarbamat
ATE136908T1 (de) Peptide und antikörper, die die integrin- ligandbindung inhibieren
EP0832973A3 (de) GTP-bindende Proteine
DE69739219D1 (de) Peptide und zusammensetzungen, die an den thrombopoietin-rezeptor binden
NO20011759L (no) Flt4 (VEGFR-3) som målmateriale for tumor-avbildning og anti- tumor-terapi
HK1040092A1 (zh) 預測和治療中風、高血壓、糖尿病和肥胖的基因和蛋白質
ATE366812T1 (de) Neue methode zur erkennung eines stoffes, der die interaktion zwischen einem tnf-liganden und seinem rezeptor auf b-zellen moduliert
WO2000005367A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
DE69928658T2 (de) Basb029 polynucleotide und polypeptide aus neisseria meningitis
ATE464383T1 (de) Tumor antigen
DE69933679D1 (de) Darstellung des profils und katalogisierung von exprimierten proteinmarkern
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
DE69839582D1 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
DE69704269D1 (de) Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung
DK0923644T3 (da) G-koblet receptor, der udviser selektiv selektivitet for ATP
ATE414099T1 (de) Biologisch aktive peptide
AU7649996A (en) Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said protein
DE69233673D1 (de) Protein S polypeptide und deren Verwendungen
NO974713L (no) Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
ATE397069T1 (de) Basb205 polypeptide und dafür kodierende polynukleotide
IL139951A0 (en) Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
EP0893501A3 (de) ATP-bindendes Ferrichrome Transportprotein
ATE399205T1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition